Sign in

CIK 0001856725

  • Emerging growth company

Rani Therapeutics Holdings, Inc.

Sign in to watch
Ticker
RANI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
863114789
Phone
+1 408-457-3700
Business address
47709 FREMONT BLVD, FREMONT, CA, 94538
  1. 4 Open-market buy 10% owner bought 17,968 shares at an average $5.67 ($101,917)
  2. 4 Open-market buy 10% owner bought 19,250 shares at an average $5.23 ($100,612)
  3. 4 Open-market buy 10% owner bought 17,200 shares at an average $5.97 ($102,761)
  4. 4 Open-market buy 10% owner bought 8,400 shares at $6.03 ($50,617)
  5. 4 Open-market buy 10% owner bought 9,157 shares at $5.58 ($51,057)
  6. 4 Open-market buy 10% owner bought 13,300 shares at an average $7.59 ($100,973)
  7. 4 Open-market buy 10% owner bought 13,527 shares at an average $7.98 ($107,981)
  8. 4 Open-market buy 10% owner bought 24,550 shares at an average $8.12 ($199,440)
  9. 4 Open-market buy 10% owner bought 24,540 shares at an average $7.97 ($195,695)
  10. 4 Open-market buy 10% owner bought 13,100 shares at an average $7.47 ($97,879)
  11. 4 Open-market buy 10% owner bought 22,014 shares at an average $8.05 ($177,312)
  12. 4 Open-market buy 10% owner bought 8,202 shares at an average $7.93 ($65,040)
  13. 4 Open-market buy 10% owner bought 3,720 shares at $7.95 ($29,587)
  14. 4 Open-market buy 10% owner bought 4,196 shares at an average $7.84 ($32,898)
  15. 4 Open-market buy 10% owner bought 29,000 shares at an average $7.46 ($216,401)
  16. 4/A Open-market buy 10% owner bought 45,488 shares at an average $6.21 ($282,466)
  17. 4 Open-market buy 10% owner bought 15,192 shares at $6.90 ($104,794)
  18. 4 Open-market buy 10% owner bought 45,488 shares at an average $6.21 ($282,466)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 18,362 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Scientific Officer gave up 20,334 shares (to pay taxes)

Page 7 of 10 · 194 filings